+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 16Years +
All Genders
ID07023419

Study on How Psychiatric Disorders Affect Addiction Relapse and the Role of Screening in Hospitalized Patients

Led by University Hospital, Strasbourg, France · Updated on 2025-06-22

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying how psychiatric diagnoses affect the risk of relapse in patients hospitalized in complex detoxification units for addiction. The goal is to better understand which psychiatric conditions increase relapse risk and to improve patient care to reduce this risk. The study also evaluates how screening questionnaires can help make psychiatric diagnoses more reliable. This is an observational study involving patients aged 16 and older who were hospitalized in a specialized withdrawal unit within a defined time frame. During the study, researchers will analyze various psychiatric and addiction-related scores, including insomnia severity, depression, anxiety, PTSD, addiction severity, ADHD, autism traits, and emotion dysregulation, all measured at 22 months. Participants will not receive experimental treatments but will be observed and assessed through questionnaires and clinical evaluations over time. The study will track these psychological and addiction-related scores to understand their relationship with relapse. The research is sponsored by the University Hospital in Strasbourg, France, and participants involvement includes completing assessments during the study period until the study ends in October 2026.

CONDITIONS

Brief Title

Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse

Research Team

A

Amaury DURPOIX, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here